Nicholas Cross


Nick has advised a broad range of UK and international clients on corporate and commercial matters – from start-up/seed funding (including university spin-outs), through intermediate funding rounds (predominantly VC backed funding rounds), to exit (both private and public) – with a particular focus on the TMT and life sciences sectors.

Many of the deals Nick works on are cross-border and recent experience includes advising clinical-stage biopharmaceutical company NuCana on the UK aspects of its IPO on Nasdaq. Nick has also gained valuable commercial experience having spent three months on secondment to the in-house legal department of Capgemini plc, a multinational technology and outsourcing company.


  • BA Theology and Religious Studies with Management Studies, University of Cambridge
  • Qualified 2015


Biotech Review of the Year

Read here

What others say

“A great associate and rising star potential. Has an incredible memory and undertakes stand out research.” Legal 500 2022

Recommended For

Commercial Contracts

Related Articles